Schear Investment Advisers LLC Trims Stock Position in GE HealthCare Technologies Inc. $GEHC

Schear Investment Advisers LLC cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 49.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,412 shares of the company’s stock after selling 7,227 shares during the quarter. Schear Investment Advisers LLC’s holdings in GE HealthCare Technologies were worth $608,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $27,000. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. E Fund Management Hong Kong Co. Ltd. boosted its stake in shares of GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares in the last quarter. Maseco LLP bought a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $29,000. Finally, Eagle Bay Advisors LLC bought a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $33,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on GEHC. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Bank of America increased their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. The Goldman Sachs Group lowered their target price on shares of GE HealthCare Technologies from $97.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. BTIG Research restated a “buy” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a research note on Tuesday. Finally, Piper Sandler lowered their target price on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Hold” and an average price target of $89.77.

GE HealthCare Technologies Trading Down 1.2%

NASDAQ GEHC opened at $71.38 on Thursday. The company has a fifty day simple moving average of $75.05 and a two-hundred day simple moving average of $77.88. The stock has a market cap of $32.57 billion, a P/E ratio of 15.65, a P/E/G ratio of 1.59 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12-month low of $64.28 and a 12-month high of $89.77. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the company posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 5 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.